PMID: 19149538Jan 20, 2009Paper

Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of Type 2 Diabetes

Current Drug Targets
Rajesh GuptaManojit Pal

Abstract

Dipeptidyl peptidase IV (DPP IV) is a key regulator of insulin-stimulating hormones, glucagon-like peptide (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), thus it is a promising target for the treatment of Type 2 Diabetes mellitus (T2DM). Inhibition of plasma DPP IV enzyme leads to enhanced endogenous GLP-1 and GIP activity, which ultimately results in the potentiation of insulin secretion by pancreatic beta-cells and subsequent lowering of blood glucose levels, HbA[1(c)], glucagon secretion and liver glucose production. Various classes of structurally different DPP IV inhibitors are currently being explored and few of them such as Sitagliptin and Vildagliptin were successfully launched. These drugs have been approved as a once-daily oral monotherapy or as a combination therapy with current anti-diabetic agents like pioglitazone, glibenclamide, metformin etc. for the treatment of T2DM. Several other novel DPP IV inhibitors are in pipeline. The present review summarizes the latest preclinical and clinical trial data of different DPP IV inhibitors with a special emphasis on their DPP8/9 fold selectivity and therapeutic advantages over GLP-1 based approach.

Citations

Nov 28, 2012·The Journal of Biological Chemistry·Jie TangZhulun Wang
May 12, 2011·Journal of Cardiovascular Pharmacology·Nga N TaYan Huang
Apr 27, 2013·Journal of Cheminformatics·Christopher Southan, Andras Stracz
Aug 10, 2010·Clinical Pharmacokinetics·André J Scheen
Aug 13, 2010·Beilstein Journal of Organic Chemistry·Arumugam KodimuthaliManojit Pal
Oct 1, 2009·Future Medicinal Chemistry·Stephen J BakerYi Xia
Jun 20, 2014·Future Medicinal Chemistry·Yang Liu, Yongzhou Hu
Mar 1, 2010·Expert Review of Clinical Pharmacology·Thomas D AicherAnthony Celeste
Aug 24, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chih-Cheng ChaiPo-Shen Pan
Dec 14, 2011·Expert Opinion on Pharmacotherapy·André J Scheen
Jun 2, 2012·Expert Opinion on Drug Discovery·Kishore Vl Parsa, Manojit Pal
Sep 21, 2013·Expert Opinion on Drug Discovery·Maliheh SafaviMohammad Abdollahi
Sep 28, 2010·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Olaf KuhlmannUwe Timm
Sep 25, 2010·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Min-Koo ChoiIm-Sook Song
Feb 19, 2013·Bioorganic & Medicinal Chemistry Letters·Guohua ZhaoLawrence G Hamann
Apr 17, 2012·Bioorganic & Medicinal Chemistry Letters·Pradip JadavKalapatapu V V M Sairam
Oct 29, 2014·Journal of Medicinal Chemistry·Bikash Manandhar, Jung-Mo Ahn
Dec 24, 2009·ChemMedChem·Heiko ZettlDieter Steinhilber
Aug 17, 2010·Diabetes Research and Clinical Practice·John Gerich
Sep 10, 2015·Biomedit︠s︡inskai︠a︡ khimii︠a︡·A A Spasov, N I Chepljaeva
Aug 27, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Robert J GreeneJ Greg Slatter
Apr 5, 2011·Diabetes Research and Clinical Practice·Roland ChenMark Kirby
Mar 14, 2012·Diabetes Research and Clinical Practice·Hamendra Singh ParmarAnil Kumar
Jul 26, 2011·Journal of Medicinal Chemistry·Artur MuchaŁukasz Berlicki
Oct 17, 2016·Life Sciences·P Sneha, C George Priya Doss
Nov 9, 2012·The Annals of Pharmacotherapy·Haesuk ParkKaren L Rascati
Jun 18, 2019·Expert Opinion on Therapeutic Patents·Hidayat HussainIftikhar Ali
Mar 13, 2012·Pharmacological Reviews·E J Verspohl
May 3, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Suocheng HuiMantian Mi
Jul 1, 2020·Journal of Biomolecular Structure & Dynamics·Vikas KumarFiroz Anwar
Jun 13, 2012·Clinical Pharmacokinetics·Larry K GolightlyMichael T McDermott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.